Stockreport

Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Pa...

Gain Therapeutics, Inc.  (GANX) 
PDF company leading the discovery and development of the next generation of allosteric small molecule therapies, announces positive results from the single ascending dose (S [Read more]